{
  "trial_id": "NCT00900627",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race, ECOG performance status, tumor type, HER2 expression level, prior treatments, baseline tumor size, baseline laboratory values (e.g., kidney function, liver function), life expectancy, presence of brain metastases, baseline comorbidities.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Stratification: Prior taxane",
          "prior treatments"
        ],
        [
          "Stratification: Hormone receptor status",
          "HER2 expression level"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Stratification: Prior chemotherapy"
      ],
      "remaining_candidate_features": [
        "ECOG performance status",
        "tumor type",
        "baseline tumor size",
        "baseline laboratory values (e.g., kidney function, liver function)",
        "life expectancy",
        "presence of brain metastases",
        "baseline comorbidities"
      ]
    },
    "processed-gen-response": "Age, gender, race, ECOG performance status, tumor type, HER2 expression level, prior treatments, baseline tumor size, baseline laboratory values (e.g., kidney function, liver function), life expectancy, presence of brain metastases, baseline comorbidities."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, HER2 expression level, Previous cancer treatments, Baseline kidney function, Baseline liver function, Baseline heart function, Baseline lung function, Baseline eye function, Life expectancy,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Stratification: Prior taxane",
          "Previous cancer treatments"
        ],
        [
          "Stratification: Hormone receptor status",
          "HER2 expression level"
        ]
      ],
      "remaining_reference_features": [
        "Stratification: Prior chemotherapy"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Baseline kidney function",
        "Baseline liver function",
        "Baseline heart function",
        "Baseline lung function",
        "Baseline eye function",
        "Life expectancy"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, HER2 expression level, Previous cancer treatments, Baseline kidney function, Baseline liver function, Baseline heart function, Baseline lung function, Baseline eye function, Life expectancy"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Eastern Cooperative Oncology Group (ECOG) performance status, Tumour type, Prior chemotherapy, Prior taxane therapy, HER2 expression level,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Stratification: Prior taxane",
          "Prior taxane therapy"
        ],
        [
          "Stratification: Prior chemotherapy",
          "Prior chemotherapy"
        ]
      ],
      "remaining_reference_features": [
        "Stratification: Hormone receptor status"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Eastern Cooperative Oncology Group (ECOG) performance status",
        "Tumour type",
        "HER2 expression level"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Eastern Cooperative Oncology Group (ECOG) performance status, Tumour type, Prior chemotherapy, Prior taxane therapy, HER2 expression level"
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, weight, height, body mass index (BMI), performance status, tumor type, tumor stage, HER2 expression level, prior chemotherapy, prior taxane therapy, life expectancy, kidney function, liver function, heart function, gastric function, lung function, eye function.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Stratification: Prior taxane",
          "prior taxane therapy"
        ],
        [
          "Stratification: Prior chemotherapy",
          "prior chemotherapy"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Stratification: Hormone receptor status"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "weight",
        "height",
        "body mass index (BMI)",
        "performance status",
        "tumor type",
        "tumor stage",
        "HER2 expression level",
        "life expectancy",
        "kidney function",
        "liver function",
        "heart function",
        "gastric function",
        "lung function",
        "eye function"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, weight, height, body mass index (BMI), performance status, tumor type, tumor stage, HER2 expression level, prior chemotherapy, prior taxane therapy, life expectancy, kidney function, liver function, heart function, gastric function, lung function, eye function."
  }
}